ft_home

Greg Abel leaves unanswered questions about Berkshire’s war chest

greg abel, warren buffett's successor at berkshire hathaway, spoke at the annual meeting but left investors with few clues about the company's massive cash pile. berkshire's war chest — which has grown to roughly $189 billion — remains a central question. abel didn't offer a clear strategy for deploying it, leaving the market guessing.

the meeting was the first since buffett's longtime partner charlie munger passed away. abel, who oversees berkshire's non-insurance operations, fielded questions alongside buffett. but on the specific topic of acquisitions or buybacks, he gave little new detail. investors had hoped for more concrete direction on how the cash would be used.

source: ft_home
sentiment: -0.20 · impact: 0.50

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

oil started the week higher on a disputed claim of an iranian strike on a u.s. navy ship in the strait of hormuz. the report, which hasn't been confirmed by u.s. officials, added fresh volatility to crude markets. the strait of hormuz is a key chokepoint

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

source: marketwatch_top sentiment: -0.70 · impact: 0.80

Warsh's take on Fed independence is met with confusion and some concern

kevin warsh, trump's pick to lead the fed, is drawing confusion from six former fed officials over his views on fed independence. the sticking point: he draws a line between monetary policy — which he says should be "strictly independent" — and "non-monetary matters" like international

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

the weight-loss and diabetes drug boom is creating a bubble risk for pharma, according to a deloitte report out monday. r&d returns for the top 20 pharma companies hit 7% for a third straight year, driven almost entirely by glp-1 drugs like wegovy and zepbound. strip those out

Read more

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

Warsh's take on Fed independence is met with confusion and some concern

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds